Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole injection vs lansoprazole injection for peptic ulcer bleeding
CTR20231884Phase 3Completed
- Sponsor
- Hunan Sailong Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), sponsored by Hunan Sailong Pharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20231884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231884.